Prevention and treatment of secondary disease--I. Effects of three non-specific agents: anti-thymocyte serum, antigen binding fragment extracted from anti-thymocyte serum and thymic chalone.
作者信息
Mathé G, Halle-Pannenko O, Kiger N, Florentin I, Bourut C
出版信息
Int J Radiat Oncol Biol Phys. 1976 Mar-Apr;1(5-6):447-54. doi: 10.1016/0360-3016(76)90010-9.
PMID:134982
Abstract
摘要
相似文献
1
Prevention and treatment of secondary disease--I. Effects of three non-specific agents: anti-thymocyte serum, antigen binding fragment extracted from anti-thymocyte serum and thymic chalone.继发性疾病的预防与治疗——I. 三种非特异性制剂的作用：抗胸腺细胞血清、从抗胸腺细胞血清中提取的抗原结合片段及胸腺抑素
Int J Radiat Oncol Biol Phys. 1976 Mar-Apr;1(5-6):447-54. doi: 10.1016/0360-3016(76)90010-9.
2
Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.抗胸腺细胞血清早期或晚期治疗后小鼠的迟发性继发性疾病。
Exp Hematol. 1973;1(4):202-14.
3
4
5
Prevention of graft-versus-host disease by Fab fragments derived from ALG.用源自抗淋巴细胞球蛋白的Fab片段预防移植物抗宿主病。
Transplant Proc. 1973 Mar;5(1):873-6.
6
An antithymocyte serum noncytotoxic to myeloid progenitor cells: candidate serum for prevention of graft-versus-host disease in bone marrow transplantation.
Clin Immunol Immunopathol. 1980 Aug;16(4):416-22. doi: 10.1016/0090-1229(80)90183-x.
7
Prevention of acute graft-versus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG).
Transplant Proc. 1973 Mar;5(1):865-8.
8
Clinical uses of anti-thymocyte globulin (ATGAM), Part II.抗胸腺细胞球蛋白（ATGAM）的临床应用，第二部分。
N C Med J. 1984 Dec;45(12):773-5.
9
10
Marrow transplantation for the treatment of acute leukemia using HL-A-identical siblings.
Transplant Proc. 1974 Dec;6(4):365-6.
Zotero 插件